Connect with us

Health

Langford mom of five sick children struggles to get COVID-19 tests – Goldstream News Gazette

Published

on


A Langford mom who believes one of her five children could be infected with COVID-19 says she can’t get a referral in order to have her daughter tested for the virus.

Jacquey Best’s 14-year-old daughter, Nevaeh, started exhibiting symptoms last Thursday — which Best says came on within a matter of hours. When Nevaeh’s fever would not subside, Best called 911 and rushed her to the hospital. After five hours of waiting in the emergency room, with a mask covering their faces, the family was told to go home and get tested for COVID-19.

The Best family spent most of February staying in hotels after their home was damaged due to the major flooding the region went through. “He understood we had stayed in hotels and said it was likely that we were high risk and to just go home, not be in public and to get tested but we haven’t been able to get tested — and now all my kids have fevers,” says Best.

Her five children, aged of four to 14, are all exhibiting symptoms now and so is Best.

READ ALSO: B.C. dentists to suspend all elective, non-essential dental work due to COVID-19

According to the BC Centre for Disease Control (BCCDC), the symptoms of COVID-19 are similar to other respiratory illnesses, including the flu and the common cold — such as cough, sneezing, fever, sore throat and difficulty breathing. Last week Island Health opened a referral-only COVID-19 screening clinic in Victoria to help support testing people for the virus. Only primary care providers or an 811 nurse is able to provide a referral, but Best says the phone lines are “clogged up” making it impossible to get a referral.

Best says she’s called both 811 and Victoria Health Unit 15 to 20 times each day since Thursday but has had no luck getting through. She says she called her doctor’s office as well but was told they haven’t been given instruction on how to deal with COVID-19 so they couldn’t help her.

READ ALSO: COVID-19: What’s open and closed in B.C. as a result of the novel coronavirus

“There shouldn’t be panic out there but there’s going to be if [people] can’t get tested and get that peace of mind,” says Best.

On Monday afternoon, Best was finally able to get in contact with Island Health and was told despite having stayed in hotels with other travelers her daughter did not meet the criteria in place for COVID-19 screening.

In response to the pandemic, the province launched a new dedicated phone service to give B.C. residents the latest information on travel recommendations and social distancing, as well as access to support and resources from the provincial and federal governments. The phone line — 1-888-COVID19 — is non-medical, in an effort to allow 811 healthcare professionals to support more people who are experiencing COVID-19 symptoms or who require assistance with other health issues. The phone line is open from 7:30 a.m. to 8 p.m., seven days a week with information available in more than 110 languages.

Best believes her children could have the virus and will continue to stay inside and self-quarantine until they can be tested.

“I believe my kids are young enough that if there’s a chance they do have this, I think they’re going to be O.K. but for anyone who’s older and elderly, I think they need to be stepping this up,” says Best.

As of Monday, B.C. has a total of 103 cases of COVID-19.

Vancouver Coastal, Fraser, Interior and Island health regions. According to a joint statement from Dr. Bonnie Henry, B.C.’s provincial health officers and Adrian Dix, Minister of Health, six of the confirmed cases are people in acute care, five have fully recovered and the rest are self-isolating at home.

To read more on COVD-19 visit vicnews.com/tag/coronavirus.



kendra.crighton@blackpress.ca

Follow us on Instagram
Like us on Facebook and follow us on Twitter.

Coronavirus

Get local stories you won’t find anywhere else right to your inbox.
Sign up here

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Insolvency trustee warns of more personal bankruptcies during COVID-19 crisis – NTV News

Published

on



.wpb_video_wrapper
opacity: 0;
transition: opacity 0.5s;

An insolvency trustee is advising households to take a close, hard look at their budgets during the COVID-19 crisis. Nancy Snedden of BDO Canada warns personal bankruptcies will increase. NTV’s Ben Cleary reports.

-Advertisement-

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Winnipeg lupus patients on edge amid shortage of drug at centre of COVID-19 trials – CBC.ca

Published

on


An unproven claim a drug used to treat lupus can combat COVID-19 is causing an increase in prescriptions of the drug, creating shortages and putting Winnipeggers who rely on it on edge. 

Elena Anciro was diagnosed with lupus eighteen years ago and relies on taking hydroxychloroquine daily in order to function without being in intense pain, and to reduce the flare-ups that make it hard to get out of bed.

“People have called this medication ‘lupus life insurance,'” Anciro said. “It is vital.”

While the drug was created in the 1950’s to treat malaria, it is commonly prescribed to control inflammation and pain for those with lupus and rheumatoid arthritis. 

However, it came to the forefront in the fight against COVID-19 thanks to a famous tweet by U.S President Donald Trump.

The tweet sent earlier this month heralded it as a possible way to treat COVID-19.

It sent people scrambling to get their hands on the drug, causing a spike in prescriptions in Manitoba and a dire warning from the province’s health regulators — it was being over-prescribed and now they are facing “serious shortages.” 

“Due to the recent yet-to-be-proven claims of effectiveness of hydroxychloroquine sulfate against COVID-19 and the growth in prescribing for it, we are now faced with a very serious shortage (and some brands, outages) of the product,” read a March 26 notice co-authored by the College of Physicians and Surgeons, Nurses and Pharmacists.

“This presents very serious challenges for long-term continuity of care for patients suffering from rheumatoid arthritis and lupus.”

Manitoba reports spike in prescriptions of hydroxychloroquine

According to the notice there has been a “significant increase” in Manitoba over the past two weeks in the number of prescriptions written and dispensed for hydroxychloroquine and Kaletra — an antiretroviral used to treat HIV.

As part of mandatory reporting requirements, a drug shortage report was given to Health Canada on March 19 by the drugs’ manufacturer, Apotex Inc. It cited the shortage was due to “demand increase” for the drug.

Anciro is just one of the 15,000 Canadians who have lupus, an autoimmune disease that cause severe inflammation of the joints among other symptoms. A further 300,000 Canadians have rheumatoid arthritis, many of whom also rely on the drug to function in their lives. 

“When Trump announced that and this all happened, to have to not only worry about getting this sick from this highly contagious virus, [but also] having to worry about the pills that allow me to be well, is very stressful,” said Anciro.

Stephanie Corbett has lupus and says if she wasn’t able to take the drug, she would have to be hospitalized and would be in immense pain. (Supplied)

Stephanie Corbett is another Winnipegger who takes hydroxychloroquine daily to treat lupus. The mother of five was diagnosed with lupus nine years ago and says without the drug, she’d likely end up in the hospital.

So far, both have been able to fill their prescription without any issues. Both say it would take weeks for the drug to leave their system, but when it does, it’ll be devastating.

“It will be life-threatening for people like me,” said Corbett. 

“I’ll end up in the hospital. The rashes will start. The pain will get worse. You know, every symptom will start rearing.”

Clinical trial at U of M

While a clinical trial is currently underway at the University of Manitoba to see if hydroxychloroquine can be repurposed to reduce the severity of COVID-19, there are currently no approved treatments or vaccines for the virus.

Virologist Jason Kindrachuk says the key message for Manitobans is they need to wait and see the outcomes of these trials before jumping to conclusions.

“The data is simply not there. I’m not arguing for or against it. I’m just saying that right now we don’t have data to support that it is actually truly beneficial for patients,” said Kindrachuk, an associate professor at the University of Manitoba and Canada research chair in emerging viruses.

Jason Kindrachuk of the University of Manitoba says the scientific community needs to explain that they are still studying these drugs and don’t know all their benefits or possible negative affects. (Jaison Empson/CBC)

He says the scientific community needs to do a better job of communicating to the public the proven benefits of a drug.

“Our biggest concern is that we don’t want to give people false hope if we truly don’t know whether or not there’s a benefit, because, again, we can have a position where people are demanding hydroxychloroquine,” Kindrachuk said 

CBC reported last week that medical regulators across the country were seeing overprescription of drugs such as hydroxychloroquine and azithromycin, another drug being studied as part of the fight against COVID-19.

Regulators reported an increase in orders for the drugs from doctors who list it as “for office use.” These requests are typically from doctors who want to keep a supply on hand for future use, raising concerns that stockpiling was occurring. 

The Manitoba College of Physicians and Surgeons cautioned its members against stockpiling, warning that it may be reviewing prescriptions of these drugs and “prescribers must be able to demonstrate good medical care.”  

“These drugs have an intended use and prescribing these drugs as a precautionary measure leads to drug shortages and is compromising care for other patients,” the College wrote on Thursday.

Chief provincial public health officer Dr. Brent Roussin talks about a new Manitoba clinical trial looking at the effectiveness of using hydroxychloroquine, which has been used for malaria and other conditions, to treat COVID-19. 1:16

A warning was only given to nurses from their regulator, warning them not to prescribe Hydroxychloroquine or azithromycin to treat COVID-19.

“Nurses have an obligation to ensure that their practice and any treatment they prescribe is evidence-informed,” wrote the College of Nurses. 

Both Corbett and Anciro say they understand Manitobans are gravitating to the drug because they are scared. 

“But as of right now, there is nothing saying that the public should to be taking it,” said Corbett.

“So leave the drug for the people with the diseases that are taking it and that need it to survive.”

Let’s block ads! (Why?)



Source link

Continue Reading

Health

FDA OK's Addition To Stockpile Of Malaria Drugs For COVID-19 – KCCU

Published

on


Over the weekend, the Food and Drug Administration granted two malaria drugs “emergency use authorization” for the treatment of COVID-19. The move makes it easier to add the medicines to the strategic stockpile, which can be drawn upon in the current public health emergency.

The drugs — chloroquine and hydroxychloroquine — have been identified as potential COVID-19 treatments based on lab tests and small, limited studies in humans.

But gold standard clinical trials in the United States only just got underway. Preliminary results from those studies aren’t expected for weeks or months.

One thing is for sure, the FDA decision doesn’t reflect an official determination that the drugs work against the coronavirus.

“This is not FDA approval of hydroxychloroquine or chloroquine for the treatment of COVID-19,” says epidemiologist Rajesh Gandhi, who is leading Massachusetts General Hospital’s COVID-19 treatment task force. “There’s an epidemic of misinformation out there, and we need to combat that.”

The emergency use authorization only applies to the supply of these two drugs in the Strategic National Stockpile, the government’s storehouses of emergency medical supplies located in warehouses throughout the country.

Hospitals would need to request access to the drugs through their states, and the medicines would only be distributed to patients who have been hospitalized and tested positive for COVID-19, but for whom a “clinical trial is not available, or participation is not feasible,” according to the FDA.

“It’s nice to know that they have it in the event we’re running low or going to run out,” says Onisis Stefas, chief pharmacy officer at Northwell Health in New York, where doctors are already using the drug for patients who can’t be enrolled in clinical trials. “It’s good to have this as backup.”

The emergency use authorization won’t affect patients seeking this drug from their local pharmacies, where shortages have been reported.

Sandoz, the generic and biosimilar arm of drugmaker Novartis, donated 30 million doses of hydroxychloroquine to the stockpile. Bayer Pharmaceuticals donated 1 million doses of chloroquine. The Department of Health and Human Services announced on Sunday that it accepted these doses “for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

President Trump began promoting both drugs at his daily coronavirus press briefings earlier this month, prompting a spike in hydroxychloroquine prescriptions and concern about shortages and accidental poisonings.

If the drugs were helpful, doctors would be pleased to have a treatment option.

“We were told patients with COVID-19 who received this drug cleared the virus better than patients that did not receive the drug,” says Francois Nosten, who directs the Shoklo Malaria Research Unit in Thailand, and has been working with chloroquine and hydroxychloroquine for decades. “But it’s not sufficient information to be sure that this drug can be used or should be used in treating patients more widely.”

Preliminary findings often don’t pan out.

“The whole history of infectious disease is littered with drugs we all thought were going to be promising but turned out … not to be,” Mass General’s Gandhi says, adding that some of these medicines even turned out to be harmful.

Copyright 2020 NPR. To see more, visit https://www.npr.org.

Let’s block ads! (Why?)



Source link

Continue Reading

Trending